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ganglion innervate the developing femur
in response to NGF expression at sites of
incipient bone formation. Functional
disruption of TrkA signaling in these
neurons impairs axon ingrowth and
retards the vascularization and
ossification of bone.
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Developing tissues dictate the amount and type of
innervation they require by secreting neurotrophins,
whichpromote neuronal survival by activatingdistinct
tyrosine kinase receptors. Here, we show that nerve
growth factor (NGF) signaling through neurotrophic
tyrosine kinase receptor type 1 (TrkA) directs innerva-
tion of the developing mouse femur to promote
vascularization and osteoprogenitor lineage progres-
sion. At the start of primary ossification, TrkA-positive
axons were observed at perichondrial bone surfaces,
coincident with NGF expression in cells adjacent to
centers of incipient ossification. Inactivation of TrkA
signaling during embryogenesis in TrkAF592A mice
impaired innervation, delayed vascular invasion of
the primary and secondary ossification centers,
decreased numbers of Osx-expressing osteoproge-
nitors, and decreased femoral length and volume.
These same phenotypic abnormalities were observed
in mice following tamoxifen-induced disruption of
NGF in Col2-expressing perichondrial osteochondral
progenitors. We conclude that NGF serves as a skel-
etal neurotrophin to promote sensory innervation of
developing long bones, a process critical for normal
primary and secondary ossification.INTRODUCTION
The formation of the vertebrate skeleton requires the action of
both intrinsic and extrinsic inductive factors from multiple cell
types, which function in a hierarchical and temporal fashion to
control skeletal patterning and osteogenic progenitor differentia-
tion (Olsen et al., 2000). During the development of endochondralThis is an open access article under the CC BY-Nbones of the limbs, osteochondral precursor cells in mesen-
chymal condensates differentiate into chondrocytes, forming an
anlage that defines the site and dimension of the mature bone.
Distinct groups of these mesenchymal cells form discrete layers
at the periphery of the anlage, giving rise to the perichondrium.
Fate-mapping studies have shown compelling evidence that
chondrocyte descendants inhabit the perichondrium and commit
to the osteoblast lineage under the control of Osterix (Osx) and
Runx2 (Kronenberg, 2003). Subsequent inductive cues (e.g.,
vascular endothelial growth factor [VEGF]) produced by hypertro-
phic chondrocytes promote blood vessel invasion of the cartilag-
inous template, providing a conduit for cells andnutrients to arrive
at the sites of primary ossification (Gerber et al., 1999).
Developing peripheral tissues dictate the amount and type of
innervation they require by secreting specific neurotrophins,
which promote neuronal survival by activating distinct tyrosine
kinase receptors (Reichardt, 2006). The prototypic target-tis-
sue-derived neurotrophin is nerve growth factor (NGF), which
activates its high-affinity receptor neurotrophic tyrosine kinase
receptor type 1 (TrkA) to initiate signaling that supports the sur-
vival of neurons (Huang and Reichardt, 2003). This function is
facilitated by the formation of NGF-TrkA endosomes, specialized
signaling vesicles that undergo long-distance retrograde trans-
port from the distal axon to the cell body via amicrotubule-based
transport mechanism (Harrington et al., 2011; Howe andMobley,
2005; Howe et al., 2001). In addition, phosphorylation of TrkA at
the axon tip or cell body can initiate a diverse array of signals that
impact functions ranging from pain sensation to metabolic regu-
lation (Kaplan and Stephens, 1994; Scita et al., 2000).
In contrast to the large body of literature on the role of periph-
eral nerves in the development of other tissues (Kumar and
Brockes, 2012; Li et al., 2007), relatively few studies have inves-
tigated the function of peripheral nerves in the developing
skeleton. Primary afferent sensory and sympathetic axons are
known to cover the entire periosteal bone surface, are present
in mineralized bone at the regions of highest metabolic activity,
and reach deep into the marrow space (Bjurholm et al., 1988;Cell Reports 16, 2723–2735, September 6, 2016 2723
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Hill and Elde, 1991; Hukkanen et al., 1992; Mach et al., 2002;
Wojtys et al., 1990). Importantly, the vast majority of nerves in
mature bone are thinly myelinated or unmyelinated sensory neu-
rons that express TrkA (Castan˜eda-Corral et al., 2011; Jimenez-
Andrade et al., 2010). Early studies demonstrated that sciatic
nerve resection in rats reduced longitudinal bone growth and
impaired fracture healing (Garce´s and Santandreu, 1988; Mad-
sen et al., 1998). In addition, mice treated with capsaicin to
chemically destroy sensory nerves exhibited decreased bone
volume along with reduced pain sensation (Heffner et al., 2014;
Offley et al., 2005). These findings in rodents are consistent
with reports from human studies that found patients with poor
nerve function have delayed or abnormal skeletal repair (Nagano
et al., 1989; Santavirta et al., 1992). While such studies provide
circumstantial support for sensory nerve function in bone, the
extent to which sensory-nerve-derived signals directly influence
bone development is unknown.
In this study, we used mouse models to visualize and disrupt
the functional signaling of the specific sensory nerves that inner-
vate the skeleton. Our results show that NGF expression in the
developing endochondral bone coincides with vascularization
and osteochondral progenitor cell expansion. Inhibition of TrkA
signaling or deletion of NGF in perichondrial osteochondral pre-
cursor cells over this time frame disrupts ossification of the pri-
mary and secondary ossification centers and impairs postnatal
bone mass and length.
RESULTS
Innervation of the Developing Mouse Femur by TrkA
Sensory Nerves Coincides with Primary Ossification
To determine the timing and location of sensory nerve invasion of
the developing mouse skeleton, we used two well-characterized
reporter mice: TrkA-LacZmice, in which one TrkA allele has been
replaced with a LacZ construct (Moqrich et al., 2004), and the
pan-neuronal Thy1-YFP mouse that expresses yellow fluores-
cent protein (YFP) under the control of neuron-specific elements
from the Thy1 gene (Feng et al., 2000). We concentrated on the
hindlimb, in which endochondral ossification of the cartilaginous
rudiments begins around embryonic day 15 (E15) in the mouse.
X-gal staining of optically cleared embryos harvested from timed
pregnant TrkA-LacZ mice revealed LacZ-positive axons inner-
vating the hindlimb via the lumbar plexus by nerves from L1 to
L6 (Figures 1A–1D). Moreover, LacZ-positive neuronal projec-
tions were observed extending into the limb and terminating
near the perichondrial region of the femur as early as E14.5 (Fig-
ure 1E, arrow). At later times in embryogenesis and postnatal life,
the TrkA sensory nerve bundles were progressively larger and
more clearly defined, with a similar overall pattern (Figures 1F–
1H). In a parallel study, optically cleared embryos from Thy1-
YFP mice were imaged using confocal microscopy to reveal
greater detail at the site of sensory nerve contact (Figures 1I–
1L). The results from the Thy1-YFP mice showed a timing and
innervation pattern identical to that seen in the TrkA-LacZmouse,
in agreement with previous reports that the sensory nerves in the
mouse skeleton mainly express TrkA (Castan˜eda-Corral et al.,
2011). Confocal imaging of whole-mounted and cleared hin-
dlimbs with muscle removed revealed thin YFP-positive axonal2724 Cell Reports 16, 2723–2735, September 6, 2016projections terminating at the perichondrial surface adjacent to
sites of incipient ossification at E14.5 (Figure 1M). By E16.5,
YFP-positive axons densely covered the perichondrial surface,
and became more abundant by E18.5 (Figures 1N and 1O). By
postnatal day 0, thin nerve projections had covered the entire
mineralizing bone collar but ended at the growth plate, with no
axonsobserved extending into thecartilaginous ends (Figure 1P).
NGF Expression in Perichondrial Cells Adjacent to the
Femoral Primary Ossification Center
As discussed above, NGF has been identified as the neurotro-
phin for TrkA sensory nerves and acts through retrograde
signaling to promote neuronal survival and provide axon guid-
ance. Therefore, we determined the pattern of NGF expression
in developing femurs over the time period of TrkA innervation us-
ing a previously validated NGF-EGFP reporter mouse (Kawaja
et al., 2011). In the developing femur, NGF expression was first
observed at E14.5 in small discrete groups of perichondrial
cells immediately adjacent to the site of incipient mineralization
in the primary ossification center (Figure 2A). Immunohistochem-
istry was performed against PECAM1 (CD31) to mark invading
vasculature and against Osx to mark prehypertrophic chondro-
cytes and osteoblast lineage cells. Expression of NGF by
perichondrial cells was observed as early as E14.5 (Figure 2B),
preceding vascular invasion of the primary ossification center
(Figure 2C). At this time point, Osx-expressing chondrocytes
were observed in primary ossification center as well as in the
perichondrium, where they were adjacent to NGF-expressing
cells (Figure 2D, arrow). At later embryonic time points (E16.5
and E18.5), NGFwas no longer expressed exclusively in the peri-
chondrial region and was abundant on newly forming trabecular
bone surfaces within the primary ossification center (Figure S1).
A similar pattern of NGF expression in the developing mouse fe-
mur over this developmental time frame was observed using
immunohistochemistry with antibodies against NGF (Figure S2).
Immediately following birth, NGF expression remained robust on
bone surfaces within the developing bone (Figure 2E). At the
femoral metaphysis, NGF-expressing cells (Figure 2F) did not
appear to be associated with vasculature, as visualized by
CD31 expression (Figure 2G). Although some NGF-expressing
cells in the femoral metaphysis were closely associated with
Osx-expressing cells (Figure 2H, arrows), most cells expressing
NGF at this time point were not. By postnatal day 7, NGF expres-
sion in the developing limb had generally declined throughout
the bone with the exception of limited expression at the growth
plate (Figure S3), consistent with the downregulation of TrkA in
the dorsal root ganglion (DRG) during this time frame (Molliver
and Snider, 1997). Brain sections were used as a positive control
for NGF expression in NGF-EGFP mice (data not shown).
Consistent with the expression of NGF in vivo, analysis of NGF
mRNA in both primary osteoblasts and mesenchymal stromal
cells (MSCs) in vitro showed high levels of expression in freshly
plated cells, which fell to a baseline level as cells differentiated
(Figure S5A). Collectively, these results are compatible with our
hypothesis that NGF expressed by perichondrial cells acts as
the neurotrophic agent for the innervation of the skeleton, result-
ing in adult bones that are predominantly occupied by TrkA
sensory nerves.
Figure 1. Innervation of the Developing Mouse Hindlimb by TrkA Sensory Nerves
(A–D) TrkA-LacZ embryos were subjected to X-gal staining, then imaged intact at (A) E14.5, (B) E16.5, (C) E18.5, and (D) postnatal day 0 (P0).
(E–H) Hindlimbs were then removed and imaged separately to illustrate the medial aspect of the femur at (E) E14.5, (F) E16.5, (G) E18.5, and (H) P0.
(I–P) Femurs from Thy1-YFP embryos were carefully stripped of soft tissue, optically cleared, and imaged by confocal microscopy at (I) E14.5, (J) E16.5, (K) E18.5,
and (L) P0.5, with high-powered insets (M–P) that show the progressive arborization of nerves on the surface of the bone.
Arrows indicate TrkA-LacZ+ nerve axon at the perichondrial region. Scale bars, 100 mm.Inhibition of TrkA Signaling in Sensory Nerves
Attenuates Innervation, Vascularization, and Primary
Ossification
Mice with the unrestricted loss of TrkA die shortly after birth with
severe neuropathies (Crowley et al., 1994; Smeyne et al., 1994),
limiting their utility for studying the role of NGF-TrkA signaling. Tocircumvent these problems, we used a mouse in which TrkA
signaling can be acutely disrupted over defined windows of
time. TrkAF592A mice are homozygous for TrkA knockin alleles
that encode a phenylalanine-to-alanine substitution in the pro-
tein kinase subdomain V, rendering its catalytic activity sensi-
tive to specific inhibition by the membrane-permeable smallCell Reports 16, 2723–2735, September 6, 2016 2725
Figure 2. Localization of NGF Expression in the Developing Mouse Femur
(A and B) Femurs harvested from NGF-EGFP mice at E14.5 illustrate the expression of NGF at the perichondrial surface (A), with high-powered inset showing
NGF-expressing perichondrial cells (arrows) at the primary ossification center (B).
(C) Immunohistochemistry against CD31 illustrated that the primary ossification center is not yet vascularized.
(D) Immunohistochemistry against Osx marked some chondrocytes in the primary ossification center as well as perichondrial cells closely associated with NGF
expression (arrow).
(E and F) Femurs harvested fromNGF-EGFPmice at P0 illustrate the continued expression of NGF throughout the developing bone (E), with high-powered inset at
the growth plate (F).
(G) Immunohistochemistry against CD31 showed high vascularization but no correlation with NGF expression.
(H) Immunohistochemistry against Osx indicates close association of some Osx-expressing cells with NGF expression (arrows).
Scale bars, 100 mm. See also Figures S1–S3.molecule 1NMPP1 (Chen et al., 2005). To validate this model, we
determined the effect of 1NMPP1 on dissociated DRG neurons
harvested from E13.5 TrkAF592Amice and cultured inmicrofluidic
chambers (Figure 3A). Treatment of neuronal preparations with
1NMPP1 attenuated the NGF-dependent axonal outgrowth of
these neurons in a dose-dependent fashion (Figures 3B–3E). In
separate experiments, mouse MSCs expressing a GFP reporter
were transfected with an NGF expression plasmid or control
plasmid and plated in microfluidic chambers opposite of DRG
neurons cultured in media containing suboptimal NGF. In this
setting, axonal infiltration was significantly increased in cultures2726 Cell Reports 16, 2723–2735, September 6, 2016of NGF-transfected MSCs (Figures 3F–3H). The ability of
1NMPP1 to inhibit TrkA in vivo was confirmed by the marked
reduction in TrkA phosphorylation 24 hr after a single intraperito-
neal (IP) injection of 1NMPP1 (17 mg/g body weight) in intact
DRGs by immunohistochemistry (Figures 3I and 3J) and by
immunoblotting of DRG extracts (Figures 3K and 3L). To deter-
mine the effect of inhibiting TrkA signaling during embryogen-
esis, pregnant heterozygous (TrkAF592A/wt) mice that carried the
Thy1-YFP transgene were provided drinking water containing
1NMPP1 (40 mM), starting at the time of mating and continuing
until birth. TrkAF592A;Thy1-YFP offspring exhibited decreased
Figure 3. Inhibition of NGF-Dependent TrkA Signaling by 1NMPP1
(A) Amicrofluidic device was used to culture DRG neurons plated in the blue compartment to project axons through microchannels (3 mmhigh3 10 mmwide) into
the red compartment for visualization.
(B–E) Neuron outgrowth was visualized in (B) positive control (DMSO + NGF), (C) negative control (DMSO alone), (D) low-dose (20 nM 1NMPP1 + NGF), and (E)
high-dose (200 nM 1NMPP1 + NGF) cultures.
(F–H) MSCs were transfected with (F) control or (G) NGF cDNA and plated in the red compartment using media with suboptimal NGF, with (H) axon infiltration
quantification.
(I and J) DRGs were sectioned and stained with antibodies against pTrk in TrkAwt;Thy1-YFP (I) and TrkAF592A;Thy1-YFP (J) adult mice 24 hr after 1NMPP1
administration.
(K and L) Western blot against pTrk with loading control on protein extracted from DRGs of adult TrkAF592A;Thy1-YFP mice injected with DMSO or 1NMPP1 (K),
with quantification (L).
(M–O) Whole-mount fluorescence imaging of intact DRGs at postnatal day 7 from TrkAwt;Thy1-YFP (M) and TrkAF592A;Thy1-YFP (N) littermates treated with
1NMPP1 during gestation with quantification (O).
(P–R) Whole-mount fluorescence imaging of skin at postnatal day 7 from TrkAwt;Thy1-YFP (P) and TrkAF592A;Thy1-YFP (Q) littermates treated with 1NMPP1
during gestation, with quantification (R).
Results are presented as mean ± SE. *p < 0.05 by unpaired Student’s t test.DRG size with altered morphology (Figures 3M–3O) as
well as diminished skin innervation at birth as compared to
TrkAwt;Thy1-YFP littermate controls (Figures 3P–3R).
Using this protocol, we next determined the effect of TrkA in-
hibition on femur development in the immediate postnatal
period. TrkAF592A;Thy1-YFP mice had significantly reduced den-
sity of Thy1-YFP+ nerves in the distal metaphysis of the femur
(Figures 4A–4D). This result was confirmed by immunohisto-
chemistry against the pan-neuronal marker PGP9.5 (Figures
S4A–S4C) as well as against TrkA (Figures S4D–S4F). Further-
more, TrkAF592A;Thy1-YFP mice had significantly reduced
vascular density at the distal metaphysis of the femur, as indi-
cated by CD31 staining (Figures 4E–4H). Analysis of H&E-
stained sections showed no gross defects in organization or
size of the growth plate in TrkAF592A;Thy1-YFP mice (Figures
4I–4L). However, skeletal preparations using alizarin red andalcian blue revealed shorter and thinner femurs in TrkAF592A;
Thy1-YFP mice than in TrkAwt;Thy1-YFP littermates (Figures
4M and 4N). This result was quantitatively confirmed by micro-
computed tomography (micro-CT) analysis, in which TrkAF592A;
Thy1-YFPmice displayed significantly diminished femoral length
(11%, 12%), reduced overall bone volume (20%, 22%),
and decreased polar moment of inertia (24%, 30%) at post-
natal days 0 and 7, respectively (Figures 4O–4T). We are unable
to attribute the alterations in bone morphology observed in
TrkAF592A;Thy1-YFP mice to a direct effect of 1NMPP1 on
osteoblasts, since primary osteoblasts and MSCs both have
low or undetectable TrkA mRNA expression (Figure S5B) and
increasing concentration of 1NMPP1 in differentiation media
containing NGF did not affect alkaline phosphatase or alizarin
red staining of primary osteoblast cultures after either 14 or
21 days of differentiation (Figures S5C and S5D).Cell Reports 16, 2723–2735, September 6, 2016 2727
Figure 4. Inhibition of TrkA Signaling Impairs Postnatal Innervation, Vascularization, and Bone Acquisition
(A–D) Nerves were visualized at the femoral metaphysis by Thy1-YFP expression in frozen sections from TrkAwt;Thy1-YFP (A) and TrkAF592A;Thy1-YFPmice (B) at
postnatal day 7, with high-powered insets (C and D).
(E–H) Blood vessels were visualized at the femoral metaphysis by immunohistochemistry against CD31 in frozen sections from TrkAwt;Thy1-YFP (E) and
TrkAF592A;Thy1-YFP (F) mice at postnatal day 7, with high-powered insets (G and H).
(I–L) H&E staining of TrkAwt;Thy1-YFP (I) and TrkAF592A;Thy1-YFP (J) mice at postnatal day 7 with hypertrophic zone (bracket) and proliferative zone (double
arrow) marked, with high powered insets (K and L).
(M and N) Skeletal preparations of TrkAwt;Thy1-YFP (M) and TrkAF592A;Thy1-YFP (N) femurs at postnatal day 7.
(O–T) Micro-CT analysis of TrkAwt;Thy1-YFP and TrkAF592A;Thy1-YFPmice at postnatal day 0 (O and P) and day 7 (Q and R), with quantification of bone volume (S)
and polar moment of inertia (T). *p < 0.05 by unpaired Student’s t test.
Results are presented as mean ± SE. Scale bars, 100 mm. See also Figures S4–S7.The close temporal and spatial relationship between TrkA
innervation and perichondrial osteochondral progenitors in the
developing femur (Figures 1 and 2) led us to hypothesize that de-
layed innervation may delay vascular invasion and/or reduce the
osteoprogenitor pool during primary ossification. Therefore, we
examined femurs harvested from mice at E15.5, a time point at
which hypertrophic chondrocytes have begun to undergo their
apoptotic program that facilitates vascular invasion (Kronen-
berg, 2003). Femurs from TrkAF592A;Thy1-YFP mice had signifi-
cantly diminished Thy1-YFP+ nerves located in the perichondrial
region (Figures 5A–5C). Moreover, vascular invasion of the pri-
mary ossification center was impaired in the TrkAF592A;Thy1-2728 Cell Reports 16, 2723–2735, September 6, 2016YFPmice as visualized byCD31 staining (Figures 5D–5F). Finally,
TrkAF592A;Thy1-YFP mice had a significantly diminished pool of
cells expressing the transcription factor Osx, which is known
tomark perichondrial cells that invade the cartilaginous template
to become both osteoblasts and stromal cells (Maes et al., 2010)
(Figures 5G–5I).
Disruption of NGF in Perichondrial Osteochondral
Precursors Attenuates Femoral Innervation,
Vascularization, and Ossification
The upregulation of NGF by perichondrial cells coincident with
the first TrkA axons reaching the developing long bone
Figure 5. Inhibition of TrkA Signaling Impairs Embryonic Innerva-
tion, Vascularization, and Accumulation of Osteoblast Precursors
(A–C) Frozen sections of the primary ossification center of the femur were
analyzed for Thy1-YFP+ nerves in TrkAwt;Thy1-YFP (A) and TrkAF592A;Thy1-
YFP (B) mice at embryonic day 15.5, with quantification (C).
(D–F) Similarly, blood vessels were visualized by immunohistochemistry
against CD31 in TrkAwt;Thy1-YFP (D) and TrkAF592A;Thy1-YFP (E) mice at
embryonic day 15.5, with quantification (F).
(G–I) Finally, osteoprogenitor cells were analyzed by immunohistochemistry
against Osx in TrkAwt;Thy1-YFP (G) and TrkAF592A;Thy1-YFP (H) mice at em-
bryonic day 15.5, with quantification (I).
Results are presented as mean ± SE. *p < 0.05 by Student’s t test. Scale bars,
100 mm.suggested that NGF expressed by these cells functioned as a
skeletal neurotrophic factor. Therefore, we hypothesized that
genetic deletion of NGF in these cells should yield a bone
phenotype analogous to that seen in TrkAF592A;Thy1-YFP
mice. To explore this idea, mice with floxed NGF alleles (NGFfl/fl)
(M€uller et al., 2012) weremated tomice carrying Col2-CreERT, a
construct that has been used extensively to map the fate of
early perichondrial precursors (Ono et al., 2014). Tamoxifen
(1 mg) and progesterone (1 mg) were administered to timed
pregnant mice at E11.5, a time point at which recombination
occurs throughout the developing limb, including the pro-
liferating cartilage and perichondrium (Nakamura et al., 2006).
Femurs from NGFfl/fl and NGFfl/fl;Col2-CreERT littermates
were harvested for analysis. First, immunohistochemistry
against NGF was used to confirm the complete loss of NGFthroughout the developing bone in NGFfl/fl;Col2-CreERT mice
(Figures 6A–6D). Next, staining using antibodies against
PGP9.5 (Figures 6E–6H) and TrkA (Figures S6A–S6C) revealed
decreased metaphyseal innervation in femurs from NGFfl/fl;
Col2-CreERT mice. In addition, femurs from NGFfl/fl;Col2-
CreERT mice had diminished vascularization of the distal meta-
physis, as illustrated by immunohistochemistry against CD31
(Figures 6I–6L). Similar to the results from TrkAF592A;Thy1-YFP
mice, H&E-stained sections in NGFfl/fl;Col2-CreERT mice did
not reveal any gross defects in organization or size of the growth
plate (Figures 6M–6P). Finally, femurs from NGFfl/fl;Col2-
CreERT mice at postnatal day 0 were shorter (8%), with signif-
icantly diminished bone volume (17%), as quantified by
micro-CT (Figures 6Q–6T). These results are entirely compat-
ible with the conclusion that NGF expression by perichondrial
osteochondral precursors drives TrkA signaling in sensory
nerves to mediate primary ossification.
TrkA Signaling Is Required for Formation of Secondary
Ossification Centers in the Developing Femur
During the course of these studies, we noted that mineraliza-
tion of the secondary ossification center (SOC) in femurs
from TrkAF592A;Thy1-YFP mice was delayed compared to
TrkAwt;Thy1-YFP littermates (Figures 4M and 4N). Formation
of the SOC in the murine femur occurs around postnatal day
5, involves the hypertrophic differentiation of epiphyseal chon-
drocytes, and requires the formation of vascular canals (also
known as cartilage canals) (Dao et al., 2012; Xing et al.,
2014). These structures form at the perichondrial surface of
the epiphysis at birth and ultimately penetrate to center of
the epiphysis to create a conduit for blood vessels and mesen-
chymal progenitor cells (Cole and Wezeman, 1985; Kugler
et al., 1979; Lutfi, 1970). Close inspection of hindlimbs from
TrkA-LacZ+ mice harvested at postnatal day 0 indicated TrkA
sensory axons were present at the epiphyseal surface of the fe-
mur and tibia at the time of vascular canal formation (Figure 7A,
arrowheads). Intact hindlimbs from NGF-EGFP mice harvested
at postnatal day 0 revealed cells expressing NGF at the leading
front of nascent vascular canals (Figures 7B and 7C) as well as
at positions of putative canal formation (Figures 7D and 7E).
Furthermore, cells expressing NGF were abundant throughout
the enlarged vascular canals tunneling toward the secondary
ossification center by postnatal day 7 (Figures 7F and 7G). In
addition, Thy1-YFP+ nerves from the epiphyseal surface were
observed entering and inhabiting epiphyseal vascular canals
(Figures 7H and 7I) but were distinctly absent from areas of
the epiphysis that had not been invaded (Figure 7I, asterisks).
To investigate the role that NGF-TrkA signaling may play in
the formation of epiphyseal vascular canals and subsequent
secondary ossification, offspring of pregnant heterozygous
(TrkAF592A/wt) mice that had been provided drinking water con-
taining 1NMPP1 (40 mM) from mating until sacrifice were
analyzed. In TrkAF592A;Thy1-YFP offspring, vascular canals at
postnatal day 7 were present, vascularized, and innervated
but greatly reduced in size as compared to TrkAwt;Thy1-YFP
littermates (Figures 7J and 7K). Furthermore, TrkAF592A;Thy1-
YFP mice had significantly reduced secondary ossification
bone volume, as illustrated by skeletal preparations (FiguresCell Reports 16, 2723–2735, September 6, 2016 2729
Figure 6. Disruption of NGF in Osteochondral Progenitors Produces a Skeletal Phenotype Similar to TrkAF592A Mice
Tamoxifen was administered to pregnant mothers at E11.5, and NGFfl/fl and NGFfl/fl;Col2-CreERT offspring were harvested for analysis at postnatal day 0.
(A–D) Expression of NGF was visualized at the femoral metaphysis by immunohistochemistry against NGF on frozen sections from NGFfl/fl (A) and NGFfl/fl;Col2-
CreERT (B) mice, with high-powered insets (C and D).
(E–H) Nerves were visualized at the femoralmetaphysis by immunohistochemistry against PGP9.5 on frozen sections fromNGFfl/fl (E) andNGFfl/fl;Col2-CreERT (F)
mice, with high-powered insets (G and H).
(I–L) Blood vessels were visualized at the femoral metaphysis by immunohistochemistry against CD31 on frozen sections fromNGFfl/fl (I) and NGFfl/fl;Col2-CreERT
(J) mice, with high-powered insets (K and L).
(M–P) H&E staining of paraffin sections of femurs from NGFfl/fl (M) and NGFfl/fl;Col2-CreERT (N) mice with hypertrophic zone (bracket) and proliferative zone
(double arrow) marked, with high-powered insets (O and P).
(Q–T) Micro-CT analysis of NGFfl/fl (Q) and NGFfl/fl;Col2-CreERT (R) mice, with quantification of femur length (S) and femur bone volume (T).
Results are presented as mean ± SE. *p < 0.05 by unpaired Student’s t test. Scale bars, 100 mm. See also Figures S6 and S7.7L–7M) and quantified by micro-CT (Figures 7N–7Q) at day 7
(75%) and day 14 (38%). These results illustrate that
NGF-TrkA signaling plays an essential role in secondary ossifi-
cation by a mechanism similar to that observed during primary
ossification.
DISCUSSION
In this study, we used several genetic mouse models to identify
the sensory nerves that innervate the developing mouse femur
and determine their spatiotemporal relationship to early osteo-
genic events. We show that TrkA signaling by these sensory
nerves is essential for early innervation and is required for the
normal formation of both primary and secondary ossification
centers. Moreover, we provide firm evidence that NGF produced2730 Cell Reports 16, 2723–2735, September 6, 2016by osteochondral progenitors functions as a skeletal neurotro-
phin by activating TrkA, which directs sensory nerve axons to
sites of incipient ossification. These conclusions are supported
by several observations. First, TrkA axons emanating from the
DRG innervated sites of incipient primary ossification, coincident
in time and space with the appearance of NGF expression in the
adjacent perichondrial cells. These events were recapitulated at
the secondary ossification center, an independent site of post-
natal bone formation. Importantly, inhibition of TrkA signaling
or genetic deletion of NGF from perichondrial osteochondral
progenitor cells over this developmental time frame produced
virtually identical femoral phenotypes, characterized by reduced
skeletal innervation, vascularization, and bone mass at birth. We
attribute these phenotypes to the loss of TrkA signaling in sen-
sory nerves, despite the fact that the chemical-genetic approach
Figure 7. Inhibition of TrkA Signaling Impairs Secondary Ossification
(A) Whole-mount images of TrkA-LacZ mice subjected to X-gal staining at postnatal day 0 illustrate TrkA sensory nerve axons terminating at primary ossification
centers and accessible to secondary ossification centers (arrows), with T (tibia) and F (femur) labeled.
(B and C) NGF-expressing cells were observed at the leading front of nascent vascular canals in femurs from NGF-EGFP mice at postnatal day 0 (B), with high-
powered inset (C).
(D and E) NGF expressing cells were also found at positions of putative canal formation in femurs from NGF-EGFPmice at postnatal day 0 (D), with high-powered
inset (E).
(F and G) By postnatal day 7, the marrow of the secondary ossification centers had abundant NGF-expressing cells (F), with high-powered inset (G).
(H) In TrkAwt;Thy1-YFP mice analyzed at postnatal day 7, Thy1-YFP+ nerves were found within the vascular canal (dotted line).
(I) These Thy1-YFP+ nerves had infiltrated the canal from the perichondrial region (arrows), whereas nerves were not observed in non-vascularized regions of the
epiphysis (asterisks). 1NMPP1 (40 mM) was administered to pregnant heterozygous TrkAF592A/wt mice, and pups were sacrificed at postnatal days 7 and 14.
(J and K) At postnatal day 7, TrkAwt;Thy1-YFP mice had larger and more vascularized secondary ossification canals at the distal femur (J) than TrkAF592A;Thy1-
YFP mice (K).
(L and M) TrkAwt;Thy1-YFP mice had a significantly larger secondary ossification center in the distal femur (L) than TrkAF592A;Thy1-YFP mice (M) by skeletal
preparation at postnatal day 7.
(N and O) Similarly, micro-CT reconstruction revealed that TrkAwt;Thy1-YFP mice had significantly increased bone volume (N) than TrkAF592A;Thy1-YFP mice (O)
at postnatal day 14.
(P and Q) Quantification of bone volume by micro-CT was performed at both P7 (P) and P14 (Q). *p < 0.05 by Student’s t test.
Results are presented as mean ± SE. Scale bars, 100 mm.
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used here would inhibit TrkA signaling in all cell types that ex-
press the receptor. In this regard, the ability to precisely control
the timing of TrkA inhibition over a narrow developmental time
frame is critical to our conclusion that sensory nerves are the pri-
mary target. Thus, the majority of non-neuronal cells present at
this early stage of bone development are mesenchymal osteo-
chondral progenitors, which do not express TrkA (Figure S5).
Furthermore, the few TrkA sympathetic nerve fibers that may
be present at this developmental time point would not yet be
functioning to control vascular tone (Brunet et al., 2014).
The requirement of NGF-TrkA signaling in sensory nerves for
the proper development of endochondral bone is entirely consis-
tent with the neurotrophic hypothesis that states that the expres-
sion of neurotrophins in target tissues determines the type and
density of invading nerves (Davies et al., 1987; Levi-Montalcini
and Angeletti, 1968). In addition, our work demonstrates that
these TrkA sensory nerves assist in the vascular invasion of
both primary and secondary ossification sites. In this regard,
our results are compatible with previous studies in developing
skin, which have shown that signals from nascent TrkA sensory
nerves provide essential cues necessary for patterning arterial
blood vessel branching during cutaneous vascularization (Mu-
kouyama et al., 2002). This process may be facilitated directly
through NGF-TrkA signaling, since NGF itself is capable of
inducing VEGF expression in peripheral sensory nerves by acti-
vating TrkA (Calza et al., 2001). In addition to vascularization, our
results suggest that sensory nerves may provide osteogenic
cues that promote osteoblast lineage progression by increasing
the number of cells in the primary ossification center that express
Osx (Nakashima et al., 2002). Along these lines, sensory nerves
in the adult hair follicle were shown to release sonic hedgehog
(Shh) to maintain the stem cell niche necessary for skin homeo-
stasis as well as acute wound healing (Brownell et al., 2011).
More recently, a similar process has been observed in the devel-
opment of the rodent incisor, during which the alveolar sensory
nerve within the neurovascular bundle releases Shh that acts
to support the differentiation of periarterial stem cells (Zhao
et al., 2014). Whether or to what extent TrkA sensory nerves in
bone release Shh, or any other signaling molecule, is unknown.
Because of the direct association between invading vasculature
and osteoprogenitors that may be independent of innervation
(Maes et al., 2010), it is possible that sensory nerves only play
a permissive role to enable vascularization during ossification,
rather than actively signaling to skeletal cells. Thus, the
precise mechanism that links NGF-TrkA signaling to down-
stream events regulating endochondral bone formation remains
to be determined.
In this study, we showed that diminished NGF-TrkA signaling
decreases the total volume of bone acquired during embryogen-
esis. During this relatively narrow window of time, the skeleton is
rapidly being formed and mineralized through the action of oste-
oblasts. Although osteoclasts are present at ossification sites,
their contribution to the overall bone volume is minimal. As a
result, our study design focused on osteoblast-related events,
revealing that NGF-TrkA signaling is required for normal accu-
mulation of Osterix-expressing osteoprogenitor cells (Figure 5C).
To address the possibility that osteoclasts were similarly
affected, we quantified TRAP staining in TrkAF592A;Thy1-YFP,2732 Cell Reports 16, 2723–2735, September 6, 2016NGFfl/fl;Col2-CreERT, and control newborn mice (Figure S7).
Although we observed no differences in osteoclast number,
these data are entirely compatible with our conclusion that loss
of NGF-TrkA signaling reduces bone mass primarily by attenu-
ating bone formation.
It is important in the context of this paper to discuss several
studies that examined the skeletal action of semaphorin 3A
(Sema3A), a well-characterized inhibitor of neuronal outgrowth
that is expressed in bone and cartilage. Mice with the unre-
stricted loss of Sema3A were observed to have gross defects
in the patterning and growth of the nerves, heart, and skeleton
(Behar et al., 1996), leading to subsequent work showing that
Sema3A is an osteoblast-derived factor that can suppress os-
teoclastogenesis (Hayashi et al., 2012). However, although the
specific deletion of Sema3A in the osteoblast lineage did not
affect either sensory innervation or bone volume, mice lacking
Sema3A selectively in neurons have decreased sensory innerva-
tion of bone and diminished postnatal bone mass (Fukuda et al.,
2013). In light of our results, we hypothesize that the loss of
Sema3A, either globally or selectively in neurons, disrupts TrkA
sensory neuron organization in a non-specific manner, poten-
tially affecting skeletal vascularization and/or osteochondral pro-
genitors and leading to defects in postnatal bone acquisition.
Finally, there is considerable circumstantial evidence that TrkA
sensory nerves function in the development and maintenance of
human bone. For example, mutations in the TRKA gene cause
congenital insensitivity to pain with anhidrosis (CIPA) (Indo
et al., 1996), an autosomal-recessive syndrome associated
with skeletal disorders such as short stature, tooth loss, and de-
layed fracture healing (Bonkowsky et al., 2003; Toscano et al.,
2000). Similarly, patients with familial dysautonomia (FD) have
progressive sensory neuron loss and low bone mass (Jackson
et al., 2014), as do children with perinatal brachial plexus palsy
(PBPP), a flaccid paralysis of the arm caused by nerve damage
at birth (Ibrahim et al., 2011). Finally, individuals with spinal
cord injury commonly develop osteopenia (Edwards et al.,
2014; Garland et al., 1992). These observations in humans are
entirely compatible with our findings in mice and underscore
the need for further investigation of the function of the peripheral
nervous system in the human skeleton.EXPERIMENTAL PROCEDURES
Mice
All procedures involving mice were approved by the Institutional Animal Care
and Use Committee of The Johns Hopkins University (protocol #M015M118).
TrkAF592A mice are homozygous for a phenylalanine-to-alanine point mutation
in exon 12 of the mouse Ntrk1 gene (F592A), rendering the endogenous TrkA
kinase sensitive to inhibition by the membrane-permeable small molecule
1NMPP1 (Chen et al., 2005). TrkAF592A mice are commercially available (Jack-
son Laboratory, stock 022362). TrkA-LacZmice, which have a LacZ sequence
inserted immediately downstream of the ATG in exon 1 of the mouse Ntrk1
gene (Moqrich et al., 2004), are commercially available (Jackson Laboratory,
stock 004837). Thy1-YFP mice, which harbor a transgene derived from the
mouse Thy1 gene that directs expression of YFP inmotor and sensory neurons
(Feng et al., 2000), are commercially available (Jackson Laboratory, stock
003709). NGF-EGFP mice, which express EGFP under the control of the
mouse NGF promoter, were generously donated by the Kawaja lab (Kawaja
et al., 2011). Mice with floxed Ngf alleles were generated in the Minichiello
lab (M€uller et al., 2012). Col2-CreERTmice, which can be induced by tamoxifen
to express Cre recombinase in cells that express Type II collagen (Nakamura
et al., 2006), are available commercially (Jackson Laboratory, stock 006774).
Littermate analysis was performed while blinded to genotype.
Synthesis and Administration of 1NMPP1
1NMPP1 (Lot #51-180-51)was synthesizedbyAuroraAnalytics LLCusing stan-
dard techniques (Hanefeld et al., 1996). Purity (99.2%)was confirmedbyHPLC-
UV254, and characterization by 1H nuclear magnetic resonance (NMR)
(400 MHz, DMSO-d6) was consistent with structure. Stock solution was pre-
pared at 200 mM by dissolving 1NMPP1 powder in DMSO. IP injections were
performed using a 5 mM solution at a dosage of 17 mg/g body weight. Drinking
water was prepared at 40 mM in ddH2O with 1% PBS-Tween 20.
X-Gal Staining
Whole embryos were harvested on ice, then fixed for 8 hr at 4C in 0.2% glutar-
aldehydecontaining 5mMEGTA,10mMMgCl2, and 100mMNaH2PO4 (pH7.3).
Following this, eachspecimenwasstainedovernight at4C inX-gal solutioncon-
taining 20 mM Tris-HCl (pH 7.5) 5 mM potassium ferricyanide, 5 mM potassium
ferrocyanide, and 1 mg/ml X-gal. After post-fixation in 4% paraformaldehyde
(PFA) at 4C overnight, the embryos were cleared using increasing concentra-
tions of glycerol (20%, 50%, and 80%), brought to final volume with 1% potas-
sium hydroxide (KOH). Finally, each embryo was placed in 100% glycerol for
imaging using a digital camera and macro lens (Fujifilm XT-1, 60 mm f2.4).
Skeletal Preparation
Whole embryos were harvested on ice to remove skin and eviscerate organs.
The samples were incubated overnight in each 100% ethanol and 100%
acetone. Next, samples were placed in a solution containing 0.03% alcian
blue (Sigma, A5268) in 80% ethanol and 20% glacial acetic acid (Sigma,
A6283) for 16–24 hr. After sufficient cartilaginous staining, samples were
washed in 70%ethanol for 2 hr and95%ethanol overnight. Following this, sam-
pleswere placed in a 1%KOHsolution for 1 hr at room temperature. Next, sam-
ples were placed in a solution containing 0.005% alizarin red (Sigma, A5533) in
1% KOH for 3–4 hr. Finally, samples were incubated in a solution containing
50% glycerol in 1% KOH until clear, imaged, and stored in 100% glycerol.
Clearing and Confocal Imaging
Samples were harvested under a dissecting microscope to remove soft tissue,
then placed in 4% PFA at 4C for 16–24 hr. After three washes in PBS and
decalcification in 14% EDTA (1:20 volume) for up to 14 days at 4C, samples
were optically cleared using a modified SeeDB method (Ke and Imai, 2014).
Briefly, samples were immersed in increasing concentrations of D-()-fructose
(Sigma, F3510), with 0.5% a-thioglycerol (Sigma, M1753), up to a maximum
concentration of 80.2% (wt/wt) fructose with gentle shaking at room tempera-
ture. After obtaining sufficient clarity, intact samples were mounted on cover-
slips and imaged using confocal microscopy (Zeiss 780 LSM).
Histology
Intact hindlimbs were harvested and placed in 4% PFA at 4C for 16–24 hr.
After 3 washes in PBS, samples were decalcified in 14% EDTA (1:20 volume)
for up to 14 days at 4C. Next, samples were sunk in 30% sucrose overnight at
4C before embedding in O.C.T. media (Tissue-Tek). Sections were cut and
mounted on adhesive slides (TruBond 380). For immunohistochemistry, sec-
tions were allowed to dry overnight, thoroughly washed, blocked using PBS
with 1.5% normal serum, and incubated in primary antibody (Table S1) over-
night at 4C in a humidified chamber. The following day, slides were washed,
incubated in fluorescent secondary antibody for 1 hr at 4C, then mounted us-
ing media containing DAPI (Vectashield, H-1200). Digital images of these sec-
tions were captured using bright-field microscopy (Olympus IX-71) with a 103
or 203 objective. Imaging stitching and quantification was performed using
FIJI (Schindelin et al., 2012).
Micro-CT Analysis
Bones were dissected free of soft tissue and evaluated using a SkyScan1172
(Bruker) high-resolution micro-CT imaging system. Each bone was scanned
separately at 65 kV and 170 mA with a 0.5-mm aluminum filter to obtain a
10.9 mm voxel size. Scan slices were acquired in the transverse plane byplacing the bone parallel to the z axis of the scanner. NRecon (Bruker) was
used to reconstruct images using a beam hardening correction of 40%, and
quantitative analysis was performed using CTAn (Bruker) in accordance with
the recommendations of the American Society for Bone and Mineral Research
(Bouxsein et al., 2010).
Osteoblast Culture
Osteoblasts were isolated from calvaria of newborn mice as previously
described (Fulzele et al., 2010). Osteoblasts were incubated in a 37C humid-
ified incubator at 5%CO2. Osteoblasts were cultured to confluency and differ-
entiated in medium supplemented with 10mM b-glycerol phosphate, 50 mg/ml
ascorbic acid, and varying concentrations of 1NMPP1 or equal volume DMSO.
Osteoblast cultures were fixed using 100% ethanol. Alkaline phosphatase ac-
tivity and mineralization was determined after 14 or 21 days of differentiation
by staining with fast red TR/naphthol AS-MX phosphate (Sigma) or 40mMaliz-
arin red (Sigma), respectively.
Microfluidic Platform Assays
Microfluidic platforms, consisting of a poly-dimethylsiloxane (PDMS) device
bonded to a glass coverslip, were generated as previously described (Hos-
mane et al., 2012). Briefly, two layers of photoresist structures were generated
on a flat silicon wafer, one for the 100-mm cell chambers (SU-8 3050) and one
for the 3-mm microgrooves (SU-8 2002). After pouring PDMS over the master
mold and incubating for 1 hr at 37C, access ports were created using dermal
biopsy punch tools (Huot Instrument). Finally, each device was sterilized with
70% ethanol before plasma bonding to a sterile glass coverslip and incubating
overnight with a 200 mg/mL solution of poly-D-lysine (Sigma). For the DRG infil-
tration assay, DRGs were harvested from mice at E13.5 into ice-cold culture
medium (DMEM/F-12 supplemented with 5% fetal bovine serum [FBS], 13
penicillin/streptomycin, and 50 ng/ml NGF), as previously described (Lentz
et al., 1999). Next, DRGs were digested with 1 mg/ml collagenase A (Roche)
at 37C for 15 min, and then with 0.05% trypsin-EDTA at 37C for 7 min.
Following this, DRGswere washed three timeswith culture medium and disso-
ciated by trituration with a 1-ml pipette tip. The dissociated neurons were
plated into the microfluidic devices at a density of 104 neurons/cm2. Non-
neuronal cells were eliminated using 20 mM 5-fluoro-2-deoxyuridine and
20 mM uridine (FDU/R). Neurons were cultured for 72 hr and stained with Cell-
Tracker CMTPX Dye (Life Technologies). For co-culture of DRG neurons with
MSCs, MSCs were transfected with mouse NGF expression vector (OriGene,
MG225454) using Lipofectamine 3000 (Thermo Fisher Scientific) at 1.6 mg/106
MSCs. Separately, DRG neurons were cultured in the middle microfluidic
chamber as described above. Four hours after transfection (20 hr after starting
DRG culture), the MSCs were trypsinized and resuspended in complete me-
dium containing suboptimal NGF (2.5 ng/ml). Finally, 104 MSCs were plated
into the outer compartments of the microfluidic device.
Gene Expression by qRT-PCR
Total RNAwas collected fromprimary osteoblasts harvested fromneonates (as
above) or MSCs (Texas A&M Health Science Center College of Medicine Insti-
tute for RegenerativeMedicine at Scott &White) after 0, 7, and 14 days of differ-
entiation using TRIzol (Life Technologies) according to the manufacturer’s
protocol. RNA (1 mg) was then reversely transcribed using an iScript cDNA
Synthesis Kit (Bio-Rad). cDNA (2 ml) was then amplified under standard PCR
conditions using iQ SYBR Green Supermix (Bio-Rad). All cDNA samples were
run in triplicate, averaged, and normalized to endogenous b-actin expression
levels. Primer sequences (TableS2)weredesignedusingPrimer-BLAST (NCBI).
Statistics
All results are presented as mean ± SE. Statistical analyses were performed in
Prism (GraphPad) using unpaired, two-tailed Student’s t tests. A p value of less
than 0.05 was considered significant.
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